Scarica l'app Stockscreener
0.9998
1.01%
-0.0102
Dopo l'orario di chiusura:
.93
-0.0698
-6.98%
Tivic Health Systems Inc Borsa (TIVC) Ultime notizie
Valuation Update: How sensitive is Tivic Health Systems Inc to inflationRecession Risk & Real-Time Volume Triggers - baoquankhu1.vn
Tivic Health outlines $20B oncology market opportunity following strategic transformation - MSN
The Ministry of Health is interested in a new, still poorly researched drug against radiation damage. The agency sent a request to the developerthe American biotech company Tivic Health Systems. Here's what we learned - Dev.ua
Tivic Health Systems Touts Entolimod Phase 3 ARS Path, Eyes BLA in 2027-2028 at Conference - Defense World
Tivic Health Systems Stock (TIVC) Opinions on Emerging Growth Conference Presentation - Moomoo
12 Health Care Stocks Moving In Thursday's After-Market SessionBullfrog AI Hldgs (NASDAQ:BFRG), CDT Eq - Benzinga
TIVC | Tivic Health Systems, Inc. FinancialsIncome Statement - Quiver Quantitative
Valauri buys Tivic Health (TIVC) shares worth $18,008 By Investing.com - Investing.com South Africa
Valauri buys Tivic Health (TIVC) shares worth $18,008 - Investing.com
Tivic Health (TIVC) director adds 19,000 shares in open-market buy - Stock Titan
TIVC Stock Price, Quote & Chart | TIVIC HEALTH SYSTEMS INC (NASDAQ:TIVC) - ChartMill
TIVC: Entolimod advances toward BLA submission for ARS, with strong clinical and government interest - TradingView
TIVC: Entolimod nears BLA submission for ARS, targeting major oncology and radiation markets - TradingView
Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual Conference - ACCESS Newswire
Tivic Health receives Ukraine request for radiation treatment By Investing.com - Investing.com South Africa
Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod - ACCESS Newswire
Tivic Health receives Ukraine request for radiation treatment - Investing.com
Ukraine weighs Tivic radiation drug for emergency reserves - Stock Titan
Tivic Health Systems Q4 2025 Earnings Call Transcript - MarketBeat
Tivic Health Systems, Inc. (NASDAQ:TIVC) Q1 2025 Earnings Call Transcript - MSN
Tivic Health Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Tivic Health (NASDAQ: TIVC) bets on Entolimod and CDMO build-out despite losses - Stock Titan
Tivic CEO to present at the Upcoming Emerging Growth's April 2026 Virtual Conference - marketscreener.com
Tivic CEO To Present at Emerging Growth Virtual Conference - National Today
New Tivic CEO to spotlight NIAID radiation study deal online - stocktitan.net
Tivic Health secures NIH funding for radiation syndrome study By Investing.com - Investing.com South Africa
Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation Syndrome - National Today
Tivic Health secures NIH funding for radiation syndrome study - Investing.com
U.S.-funded Tivic study targets deadly gut damage after radiation - Stock Titan
Tivic Health Systems, Inc. Relocates Headquarters to San Antonio, Texas and Discontinues ClearUP Operations - Minichart
Earnings call transcript: Tivic Health pivots to biopharma focus in Q4 2025 By Investing.com - Investing.com South Africa
Earnings call transcript: Tivic Health pivots to biopharma focus in Q4 2025 - Investing.com India
TIVC: Transformed into an immunotherapy-focused company with expanded manufacturing and strong cash reserves - TradingView
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Transcript : Tivic Health Systems, Inc., 2025 Pre Recorded Earnings Call, Mar 25, 2026 - MarketScreener
Tivic Health Unveils 2025 Results and Strategic Pivot - TipRanks
Tivic Health (Nasdaq: TIVC) pivots to Entolimod immunotherapy and CDMO model - stocktitan.net
TIVC: Shifted to immunotherapy, expanded pipeline, and improved cash position despite higher losses - TradingView
Tivic Reports Full Year 2025 Results - ACCESS Newswire
Tivic shuts consumer business, builds immunotherapy and CDMO arms - Stock Titan
Biotech Company Tivic Health Aims to Advance Immunotherapy Research Programs - USA Today
How do insiders feel about Tivic Health Systems IncWeekly Trade Review & Risk Controlled Swing Alerts - baoquankhu1.vn
Tivic Health CEO Letter to Shareholders - Bitget
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):